rs199538589
Positions:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_004807.3(HS6ST1):c.1144C>T(p.Arg382Trp) variant causes a missense change. The variant allele was found at a frequency of 0.0012 in 1,611,496 control chromosomes in the GnomAD database, including 21 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0010 ( 2 hom., cov: 34)
Exomes 𝑓: 0.0012 ( 19 hom. )
Consequence
HS6ST1
NM_004807.3 missense
NM_004807.3 missense
Scores
1
13
4
Clinical Significance
Conservation
PhyloP100: 5.54
Genes affected
HS6ST1 (HGNC:5201): (heparan sulfate 6-O-sulfotransferase 1) The protein encoded by this gene is a member of the heparan sulfate biosynthetic enzyme family. Heparan sulfate biosynthetic enzymes are key components in generating a myriad of distinct heparan sulfate fine structures that carry out multiple biological activities. This enzyme is a type II integral membrane protein and is responsible for 6-O-sulfation of heparan sulfate. This enzyme does not share significant sequence similarity with other known sulfotransferases. A pseudogene located on chromosome 1 has been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.018632412).
BP6
Variant 2-128268254-G-A is Benign according to our data. Variant chr2-128268254-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 180161.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 2 AD,AR,Digenic,Multigenic gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HS6ST1 | NM_004807.3 | c.1144C>T | p.Arg382Trp | missense_variant | 2/2 | ENST00000259241.7 | NP_004798.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HS6ST1 | ENST00000259241.7 | c.1144C>T | p.Arg382Trp | missense_variant | 2/2 | 1 | NM_004807.3 | ENSP00000259241.6 | ||
HS6ST1 | ENST00000469019.1 | n.361-21729C>T | intron_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.000992 AC: 151AN: 152180Hom.: 2 Cov.: 34
GnomAD3 genomes
AF:
AC:
151
AN:
152180
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00188 AC: 464AN: 246850Hom.: 3 AF XY: 0.00251 AC XY: 337AN XY: 134514
GnomAD3 exomes
AF:
AC:
464
AN:
246850
Hom.:
AF XY:
AC XY:
337
AN XY:
134514
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00122 AC: 1774AN: 1459198Hom.: 19 Cov.: 32 AF XY: 0.00155 AC XY: 1128AN XY: 725838
GnomAD4 exome
AF:
AC:
1774
AN:
1459198
Hom.:
Cov.:
32
AF XY:
AC XY:
1128
AN XY:
725838
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000998 AC: 152AN: 152298Hom.: 2 Cov.: 34 AF XY: 0.00125 AC XY: 93AN XY: 74468
GnomAD4 genome
AF:
AC:
152
AN:
152298
Hom.:
Cov.:
34
AF XY:
AC XY:
93
AN XY:
74468
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
3
ESP6500EA
AF:
AC:
3
ExAC
AF:
AC:
257
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Pathogenic:1Uncertain:2Benign:5Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:1Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 24, 2020 | This variant is associated with the following publications: (PMID: 21700882, 23643382, 26207952, 27535533, 30669598) - |
Uncertain significance, flagged submission | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The HS6ST1 p.R382W variant was identified in 5 of 1590 proband chromosomes (frequency: 0.00314) from individuals or families with idiopathic hypogonadotropic hypogonadism (Zhu_2015_PMID:25636053, Miraoui_2013_PMID:23643382, Tornberg_2011_PMID:21700882). The variant was identified in dbSNP (ID: rs199538589) and in ClinVar (classified as likely pathogenic by the Chan Lab at Boston Children's Hospital and benign by Laboratory for Molecular Medicine, Partners HealthCare Personalized Medicine with the associated condition of hypogonadotrophic hypogonadism). The variant was also identified in control databases in 480 of 278216 chromosomes (3 homozygous) at a frequency of 0.001725 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: South Asian in 337 of 30560 chromosomes (freq: 0.01103), Ashkenazi Jewish in 35 of 10268 chromosomes (freq: 0.003409), Latino in 31 of 35288 chromosomes (freq: 0.000879), African in 16 of 23958 chromosomes (freq: 0.000668), European (non-Finnish) in 56 of 126664 chromosomes (freq: 0.000442), Other in 3 of 7078 chromosomes (freq: 0.000424) and East Asian in 2 of 19480 chromosomes (freq: 0.000103), but was not observed in the European (Finnish) population. The p.Arg382 residue is conserved in mammals but not in more distantly related organisms, and four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) suggest that the variant may impact the protein; however, this information is not predictive enough to assume pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In vitro functional analysis demonstrated a 25 to 35% reduction in enzymatic activity with the p.R382W mutant compared to wildtype, and in an in vivo assay involving C. elegans, the p.R382W mutant displayed a reduced capacity to rescue a kal1-dependent axon branching phenotype compared to wildtype HS6ST1 (Tornberg_2011_PMID:21700882). Tornberg et al. (2011) identified the p.R382W variant in three unrelated individuals with hypogonadotropic hypogonadism: a female and two males (1 with anosmia and 2 with a normal sense of smell). The female proband had a brother with delayed puberty who did not carry the HS6ST1 p.R382W mutation, whereas the anosmic male proband had an unaffected brother who did carry the mutation, indicating that the variant did not segregate with disease (Tornberg_2011_PMID:21700882). In summary, based on the above information this variant meets our laboratory's criteria to be classified as benign. - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 27, 2023 | - - |
Hypogonadotropic hypogonadism 7 with or without anosmia Pathogenic:1Benign:1
Likely pathogenic, flagged submission | case-control | Chan Lab, Boston Children's Hospital | Nov 01, 2014 | - - |
Benign, criteria provided, single submitter | clinical testing | Mendelics | Aug 22, 2023 | - - |
HS6ST1-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 20, 2023 | The HS6ST1 c.1144C>T variant is predicted to result in the amino acid substitution p.Arg382Trp. This variant has been reported in multiple unrelated patients with hypogonadotropic hypogonadism (referred to as R372W in Tornberg et al. 2011. PubMed ID: 21700882; Miraoui et al. 2013. PubMed ID: 23643382; Zhu et al. 2015. PubMed ID: 25636053), and was defined as a founder allele in Caucasian and South Asian ethnicities (Choi et al. 2015. PubMed ID: 26207952, Table 2). In vitro and in vivo functional studies showed that the p.Arg382Trp variant resulted in reduced enzymatic activity compared to wild-type (referred to as R372W in Tornberg et al. 2011. PubMed ID: 21700882). However, this variant is found at an allele frequency of up to ~1.12% in South Asian individuals (including 3 homozygotes) in a large population database of individuals with unknown phenotype, which is likely too common to be a primary cause of autosomal dominant disease. Of note, in a recent publication, this variant was found in a patient with milder adult-onset form of hypogonadotropic hypogonadism (Cangiano et al. 2019. PubMed ID: 30669598, Table S1). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency, unrelated to patient disease - |
Hypogonadotropic hypogonadism 15 with or without anosmia Benign:1
Benign, criteria provided, single submitter | research | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | - | The heterozygous p.Arg382Trp variant in HS6ST1 has been identified in 6 individuals with idiopathic hypogonadotropic hypogonadism (PMID: 21700882, 23643382), and has been identified in >1% of South Asian chromosomes and 4 homozygotes by ExAC (http://gnomad.broadinstitute.org/). In vitro functional studies provide some evidence that the p.Arg382Trp variant may silghtly impact protein function (PMID: 21700882). However, these types of assays may not accurately represent biological function. In summary, this variant meets criteria to be classified as benign for autosomal dominant idiopathic hypogonadotropic hypogonadism. - |
HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA, SUSCEPTIBILITY TO Other:1
risk factor, no assertion criteria provided | literature only | OMIM | Jul 12, 2011 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
MetaRNN
Benign
T
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at